Margarate Boeye's questions to Adaptive Biotechnologies Corp (ADPT) leadership • Q1 2025
Question
Maggie Boeye, on for Andrew Brackmann at William Blair, asked about the sources of operating leverage, future investment priorities, and the progress on the NeoGenomics partnership ahead of its pilot launch.
Answer
CFO Kyle Piskel identified leverage from higher lab volumes and field force productivity. Executive Susan Bobulsky outlined future investments in revenue cycle management, EMR technology, and data generation, with no near-term plans to expand the sales force. She confirmed the NeoGenomics partnership is on track, with key operational planning for the Phase I launch complete.